Clinical Laserthermia Systems AB (publ)

OM:CLS UR B 株式レポート

時価総額:SEK 22.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Clinical Laserthermia Systems 将来の成長

Future 基準チェック /26

We currently don't have sufficient analyst coverage to forecast growth and revenue for Clinical Laserthermia Systems.

主要情報

56.9%

収益成長率

50.0%

EPS成長率

Medical Equipment 収益成長27.0%
収益成長率56.5%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日24 Feb 2023

今後の成長に関する最新情報

更新なし

Recent updates

更新なし

業績と収益の成長予測

OM:CLS UR B - アナリストの将来予測と過去の財務データ ( )SEK Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2025115-2N/AN/A1
12/31/202444-45-48-451
12/31/202317-70-70-671
3/31/20236-78-71-68N/A
12/31/20226-71-69-68N/A
9/30/20223-81-81-81N/A
6/30/20222-63-66-66N/A
3/31/20222-68-71-71N/A
12/31/20212-64-67-66N/A
9/30/20211-60-63-63N/A
6/30/20212-57-55-55N/A
3/31/20212-47-41-41N/A
12/31/20201-58-56-55N/A
9/30/20201-58-54-53N/A
6/30/20202-57-54-54N/A
3/31/20206-54-52-52N/A
12/31/20196-43-39-39N/A
9/30/20196-38-37-36N/A
6/30/20195-37-35-34N/A
3/31/20191-41-44-43N/A
12/31/20188-33-41-39N/A
9/30/201810-28-33-31N/A
6/30/201811-24-33-31N/A
3/31/201812-15-29-24N/A
12/31/20178-21-29-24N/A
9/30/20178-22-34-29N/A
6/30/20178-26-28-24N/A
3/31/20176-27-24-23N/A
12/31/20164-27N/A-20N/A
9/30/20161-27N/A-19N/A
6/30/20160-23N/A-22N/A
3/31/20160-20N/A-17N/A
12/31/2015N/A-17N/A-19N/A
9/30/20150-21N/A-21N/A
6/30/20150-20N/A-20N/A
3/31/20150-20N/A-19N/A
12/31/2014N/A-18N/A-16N/A
9/30/20140-16N/A-18N/A
6/30/2014N/A-16N/A-18N/A
3/31/2014N/A-17N/A-17N/A
12/31/2013N/A-18N/A-18N/A
9/30/20130-16N/A-13N/A
6/30/2013N/A-15N/A-12N/A
3/31/20130-13N/A-11N/A
12/31/2012N/A-13N/A-12N/A
9/30/20120-11N/A-10N/A

アナリストによる今後の成長予測

収入対貯蓄率: CLS UR B is forecast to remain unprofitable over the next 3 years.

収益対市場: CLS UR B is forecast to remain unprofitable over the next 3 years.

高成長収益: CLS UR B is forecast to remain unprofitable over the next 3 years.

収益対市場: CLS UR B's revenue (56.5% per year) is forecast to grow faster than the Swedish market (5.5% per year).

高い収益成長: CLS UR B's revenue (56.5% per year) is forecast to grow faster than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: Insufficient data to determine if CLS UR B's Return on Equity is forecast to be high in 3 years time


成長企業の発掘